Method and composition for blocking antigen-induced allergic...

Details Method and composition for blocking antigen-induced allergic... Method and composition for blocking antigen-induced allergic...

A - Human Necessities

61

K

167/231

A61K 31/485 (2006.01)

Patent

CA 1287301

ABSTRACT OF THE DISCLOSURE Antigen-induced allergic responses are inhibited by administration of opioid antagonists. A preferred antagonist is 6-methylene-6-desoxy-n-cyclopropylmethyl- 14-hydroxydihydronormorphine. Oral administration is preferred.

521587

Affiliated with

Also associated with

Rating

Method and composition for blocking antigen-induced allergic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and composition for blocking antigen-induced allergic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and composition for blocking antigen-induced allergic... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1310920